| Filed On | Filing |
|---|---|
| 22 Aug 2024 |
8-K/A: Entry into a Material Definitive Agreement; Regulation FD Disclosure
On August 20, 2024, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC, as the underwriter (the “Underwriter”), relating to the of... |
| 14 Nov 2023 |
8-K/A: Changes in Registrant's Certifying Accountant
We have read Item 4.01 of the Current Report on Form 8-K/A of Reviva Pharmaceuticals Holdings, Inc. dated November 14, 2023, which we understand will be filed with the Securities and Exchange Commission, and we agree with the statements ... |
| 20 Jan 2021 | 8-K/A: Changes in Registrant's Certifying Accountant; Amendments to Articles/Bylaws; Change in Fiscal Year |
Loading...
